Olaparib for Metastatic Castration-Resistant Prostate Cancer. Reply

Affiliations

¹ Institute of Cancer Research, London, United Kingdom.
² AstraZeneca, Gaithersburg, MD.
³ Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL.

Comment

Johann de Bono et al. N Engl J Med. 2020.

. 2020 Aug 27;383(9):891.

doi: 10.1056/NEJMc2023199.

¹ Institute of Cancer Research, London, United Kingdom.
² AstraZeneca, Gaithersburg, MD.
³ Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL.

No abstract available

Comment on

Olaparib for Metastatic Castration-Resistant Prostate Cancer.
Mutetwa T, Foulkes WD, Polak P. Mutetwa T, et al. N Engl J Med. 2020 Aug 27;383(9):890. doi: 10.1056/NEJMc2023199. N Engl J Med. 2020. PMID: 32846071 No abstract available.
Olaparib for Metastatic Castration-Resistant Prostate Cancer.
Heidegger I, Pircher A. Heidegger I, et al. N Engl J Med. 2020 Aug 27;383(9):890-891. doi: 10.1056/NEJMc2023199. N Engl J Med. 2020. PMID: 32846072 No abstract available.